Inhibition of the immunoproteasome LMP2 ameliorates ischemia/hypoxia-induced blood–brain barrier injury through the Wnt/β-catenin signalling pathway
Abstract Background Disruption of the blood–brain barrier (BBB) after a stroke can lead to brain injury and neurological impairment. Previous work confirmed the involvement of the immunoproteasome subunit of low molecular mass peptide 2 (LMP2) in the pathophysiology of ischemia stroke. However, the...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
KeAi Communications Co., Ltd.
2021-12-01
|
| シリーズ: | Military Medical Research |
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1186/s40779-021-00356-x |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
